PB Handbook for Psychiatric Trainees
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

Psychiatric Bulletin (2000) 24: 415-417. doi: 10.1192/pb.24.11.415
© 2000 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lowe-Ponsford, F.
Right arrow Articles by Baldwin, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lowe-Ponsford, F.
Right arrow Articles by Baldwin, D.
Psychiatric Bulletin (2000) 24: 415-417
© 2000 The Royal College of Psychiatrists

Off-label prescribing by psychiatrists

Francesca Lowe-Ponsford, Locum Consultant Psychiatrist

Bay Tree House, Graham Road, Southampton, Hants S014 0YH

David Baldwin, Senior Lecturer and Honorary Consultant Psychiatrist

Southampton University Mental Health Group, Royal South Hampshire Hospital, Brinton's Terrace, Southampton, Hants S014 0YG

A questionnaire was sent to 200 psychiatrists asking them about their off-label prescribing in the preceding month. One hundred and sixteen replies (58%) were obtained. Seventy-six (65%) respondents had prescribed medication off-label within the past month. Only 5 (4%) had ever received a complaint from patients related to their off-label prescribing. If this region is typical, off-label prescribing is common amongst psychiatrists. No formal guidelines exist except for the use of high dose neuroleptics. A suggested guideline is given in this article.




This article has been cited by other articles:


Home page
 Adv. Psychiatr. Treat.Home page
D. S. Baldwin and N. Kosky
Off-label prescribing in psychiatric practice
Advan. Psychiatr. Treat., November 1, 2007; 13(6): 414 - 422.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
C. Haw and J. Stubbs
Benzodiazepines a necessary evil? A survey of prescribing at a specialist UK psychiatric hospital
J Psychopharmacol, August 1, 2007; 21(6): 645 - 649.
[Abstract] [PDF]

Home page
 Psychiatr. Bull.Home page
R. Hodgson and R. Belgamwar
Off-label prescribing by psychiatrists
Psychiatr. Bull., February 1, 2006; 30(2): 55 - 57.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
D. Layton, S. Harris, L. V. Wilton, and S. A. W. Shakir
Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia
J Psychopharmacol, September 1, 2005; 19(5): 473 - 482.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
C. Haw and J. Stubbs
A survey of the off-label use of mood stabilizers in a large psychiatric hospital
J Psychopharmacol, July 1, 2005; 19(4): 402 - 407.
[Abstract] [PDF]

Home page
 Psychiatr. Bull.Home page
J. Johnson and A. F. Clark
Prescribing of unlicensed medicines or licensed medicines for unlicensed applications in child and adolescent psychiatry
Psychiatr. Bull., December 1, 2001; 25(12): 465 - 466.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2000 The Royal College of Psychiatrists.